Natural Cycles
PrivateLast Round
Series C
May 29, 2024
Total Funding Raised
$99.5M
Company Overview
Natural Cycles operates in Healthcare & Life Sciences and is based in Stockholm. Its latest recorded funding round was a Series C round in May 2024.
Natural Cycles is a health technology company that offers a digital birth control application empowering women to manage their reproductive health through an algorithm that predicts ovulation for non-invasive and hormone-free pregnancy planning.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, Health IoT, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Natural Cycles Comparables
Compare Natural Cycles with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clue | 88% | |
| Flo Health | 86% | |
| Glow | 81% |
For institutional investors. Book with your work email.
Natural Cycles Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 29, 2024 | ||||
| Debt | May 29, 2024 | ||||
| Strategic | Feb 14, 2023 | ||||
| Series B | Nov 9, 2017 | ||||
| Series A | Jun 23, 2016 | ||||
Seed | Jul 5, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Natural Cycles Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Heartcore Capital | Strategic, Series C, Seed, Series B, Series A |
| Bonnier Capital | Series B, Strategic, Series C, Series A |
| EQT Ventures | Strategic, Series C, Series B |
| Lauxera Capital Partners | Series C |
| Samsung Venture Investment | Strategic |
| Point72 Private Investments | Series C |
| Sunstone Management | Series B, Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Former Klarna executive Christopher Wanzelius joins in an executive role.
- Jan 15, 2026
Launched a new wristband to track temperature for its birth control app.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 7, 2026
NaturalCycles Nordic AB sponsors an educational session on digital contraception at the Society of Obstetricians and Gynaecologists of Canada's Annual Clinical and Scientific Meeting, covering its evidence base, regulatory landscape, and common misconceptions.
- expands_offices_inOct 7, 2026
NaturalCycles Nordic AB expands its investment in Canada across clinical research, medical education, and consumer awareness on Oct 7th '26.
- has_revenueAug 20, 2026
In 2025, NaturalCycles Nordic AB records $63M in revenue.
For institutional investors. Book with your work email.
Natural Cycles Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Natural Cycles's valuation, stock price, and market status.
Is Natural Cycles a public or private company?
Natural Cycles is a private company.
What is the current stock price of Natural Cycles?
Natural Cycles is a private company, so its shares have no public market price. Caplight tracks Natural Cycles's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Natural Cycles worth (valuation)?
Valuation information for Natural Cycles is not publicly available.
Can I buy Natural Cycles stock?
Natural Cycles shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Natural Cycles's last funding round?
Natural Cycles's most recent funding round was Series C on May 29, 2024.
Who are the main investors in Natural Cycles?
Key investors in Natural Cycles include Bonnier Capital, EQT Ventures, Lauxera Capital Partners, Samsung Venture Investment, Bonnier Capital.
Will Natural Cycles IPO soon?
No public IPO plans have been announced for Natural Cycles.
How can I track Natural Cycles secondary market activity?
Caplight tracks bids, offers, and trades in Natural Cycles's shares on secondary markets.